Teleflex Incorporated

Teleflex Incorporated

TFX

$121.56

Updated: 23/09/2026, 21:13:30

Market Cap
$5.38B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Stock valuation chart
One-year closing share-price history for TFX
Company Profile

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

USD
NYSE
CEO: Jason Weidman
Employees: 15,500
https://www.teleflex.com
Asset Summaries
Latest generated summaries for TFX

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for TFX.
Share price
$121.56
Market cap
$5.38B
Exchange
NYSE
Currency
USD
CEO
Jason Weidman
Employees
15,500
IPO date
17/03/1980
Beta
0.8139999999999999
Last dividend
$0.00
Day range
$121.08 – $125.69
52-week range
$100.18 – $145.00
1-day performance
-2.67%
1-year performance
21.34%
Current drawdown (1Y)
-16.17%
CIK
0000096943
CUSIP
879369106
ISIN
US8793691069
Created
07/12/2025, 14:31:59
Last update
23/09/2026, 21:13:30

Track Teleflex Incorporated with an AI analyst

See which prediction-market events move TFX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to TFX from your Railway `news_articles` table.

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Business Wire • STOCK • 09/06/2026, 08:30:00

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Business Wire • STOCK • 01/06/2026, 19:40:00

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank

Zacks Investment Research • STOCK • 01/06/2026, 13:15:22

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Business Wire • STOCK • 01/06/2026, 09:45:00

Teleflex Divestitures: What Investors Should Watch in 2026

Zacks Investment Research • STOCK • 29/05/2026, 12:50:37

Teleflex Announces Quarterly Dividend

Business Wire • STOCK • 15/05/2026, 18:30:00

TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

Zacks Investment Research • STOCK • 13/05/2026, 11:40:41

Teleflex Incorporated (NYSE: TFX) Reports Mixed Q1 2026 Earnings: Revenue Beat, GAAP Loss

Market Data • Market Data • 07/05/2026, 18:08:30

Teleflex Incorporated (TFX) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 07/05/2026, 13:01:17

Teleflex Announces First Quarter 2026 Earnings Conference Call Information

Business Wire • STOCK • 23/04/2026, 08:30:00

Teleflex Upgraded to Neutral by BofA on Improved Risk-Reward Balance

Market Data • Market Data • 13/04/2026, 17:10:13

Teleflex Announces Governance Updates

Business Wire • STOCK • 09/04/2026, 08:30:00